Successful treatment of Chromobacterium violaceum sepsis in South Africa

J Med Microbiol. 2008 Oct;57(Pt 10):1293-1295. doi: 10.1099/jmm.0.2008/001883-0.

Abstract

Chromobacterium violaceum sepsis is extremely rare and usually fatal. A very few cases of C. violaceum infection have been reported from Africa, but never from South Africa. As far as could be ascertained, this infection has never been reported in a patient with leukaemia. We describe what we believe to be the first such case of C. violaceum sepsis, in a 16-year-old female patient with acute biphenotypic leukaemia, which developed during the neutropenic phase after intensive chemotherapy. The infection was due to a non-pigmented strain of C. violaceum and was associated with a co-infection with Candida parapsilosis; both were successfully treated using broad-spectrum antibiotics, antifungals and removal of a Hickman line.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / therapeutic use*
  • Antifungal Agents / pharmacology
  • Candidiasis / complications
  • Candidiasis / drug therapy
  • Chromobacterium / isolation & purification*
  • Female
  • Gram-Negative Bacterial Infections / drug therapy*
  • Gram-Negative Bacterial Infections / epidemiology
  • Gram-Negative Bacterial Infections / microbiology
  • Humans
  • Leukemia / complications
  • Neutropenia / complications
  • Sepsis / drug therapy*
  • Sepsis / microbiology
  • South Africa / epidemiology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents